Where does Revolo Biotherapeutics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Revolo Biotherapeutics Limited ranks #42,659 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Revolo Biotherapeutics Limited hold?

Revolo Biotherapeutics Limited holds 6 US utility patents granted between 2021 and 2025, spanning 4 technology areas.

What is Revolo Biotherapeutics Limited's Innovation Score?

Revolo Biotherapeutics Limited has an Innovation Score of 39.6 out of 100 (top 38% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Revolo Biotherapeutics Limited focus on?

Revolo Biotherapeutics Limited's top technology area is C07K (Peptides) with 6 patents, ranking #1,362 of 3,615 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Revolo Biotherapeutics Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Revolo Biotherapeutics Limited.

What does claim depth mean for Revolo Biotherapeutics Limited's patents?

Revolo Biotherapeutics Limited's patents average 20.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Revolo Biotherapeutics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Revolo Biotherapeutics Limited

USPTO PatentsView assignee record - 6 granted patents across 4 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Revolo ranks #42,659 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 4 technology areas.

#42,659
of 49,997 US assignees by volume: Top 38%
by Innovation Score (39.6/100): 20.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R42659 · Foreign Corporation #42,659 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #42,659/49,997
PHOTO-FINISH Revelution Technology
CPC-NARROW C07K · 4 areas
INNOV-THIN 39.6/100
CLAIMS-DENSE 20.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Revelution Technology, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Revolo’s 39.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (17%) Velocity 13.3 pts (34%) Breadth 7.1 pts (18%) Claim depth 12.5 pts (32%)

Qualcomm Incorporated · highest

85
Revolo Biotherapeutics · this assignee

40
3D Lighting… · lowest

7

What this shows Revolo's Innovation Score is 39.6/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Revolo?

Each dot is one of Revolo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Revolo’s own 20.8 claims/patent is ABOVE the 14.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Revolo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Revolo's grants concentrate

Revolo Biotherapeutics Limited is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Revolo sits between Revelution Technology, LLC and Rheosense, Inc..

Revolo's three-year grant acceleration

Revolo Biotherapeutics Limited shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Revelution Techno…

6
Revise Products

6
Revive Environmen…

6
Revive Solutions

6
Revolution Lighti…

6
Revolution Retail…

6
Rgenix

6
Rheosense

6
Revolo Biotherape… ◀

6

What this shows Revolo holds 6 patents at rank #42,678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Revolo

By rank, the assignees closest to #42,678 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Revolo's primary technology class.

Revolo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 38% higher than 62% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Revolo Biotherapeutics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	1	16.7%
2022	1	16.7%
2023	1	16.7%
2025partial year	3	50.0%

Which technologies does Revolo Biotherapeutics Limited patent most?

C07K - Peptides 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Revolo Biotherapeutics Limited's patent record in context - here's where to go next.

Revolo Biotherapeutics Limited's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #42,659 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Revolo Biotherapeutics Limited against Revelution Technology, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 39.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.